Letter

LIFT study to continue as planned

BMJ 2005; 331 doi: 10.1136/bmj.331.7520.843-a (Published 6 October 2005)
Cite this as: BMJ 2005;331:843.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Diederick E Grobbee, professor of clinical epidemiology (grobbee@umcutrecht.nl) On behalf of the LIFT Steering Committee
  1. Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, HP DO1.335, PO Box 85500, 3508 GA Utrecht, Netherlands

    EDITOR—The long term intervention on fractures with tibolone (LIFT) study is a randomised trial to determine the effect of treatment with tibolone on risk of vertebral fracture in older osteoporotic postmenopausal women. The average age of the 4538 participants is 68 (SD 5.2) years. They have a bone mineral density t score at the total hip or spine ≤ - 2.5 without …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular